Luca Petrizza

Luca Petrizza

Auto-generated profile, based on publicly available information

Luca Petrizza

University of Bologna

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2016 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GVGiovanni Valenti
Giovanni Valenti
EREnrico Rampazzo
Enrico Rampazzo
SBSara Bonacchi
Sara Bonacchi
LPLuca Petrizza
Luca Petrizza
MMMassimo Marcaccio
Massimo Marcaccio
FPFrancesco Paolucci
Francesco Paolucci

1 April 2013 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
WAW. Arap
W. Arap
RPR. Pasqualini
R. Pasqualini
MMMarco Montalti
Marco Montalti
LPL. Petrizza
L. Petrizza
LPLuca Prodi
Luca Prodi
Serena MarchiòSerena Marchiò
Serena Marchiò
Fluorescence imaging techniques are becoming essential for preclinical investigations, necessitating the development of suitable tools for in vivo measurements. Nanotechnology entered this field to help overcome many of the current technical limitations, and luminescent nanoparticles (NPs) are one of the most promising materials proposed for future diagnostic implementation. NPs also constitute a versatile platform that can allow facile multi-functionalization to perform multimodal imaging or theranostics (simultaneous diagnosis and therapy). In this contribution we have mainly focused on dye doped silica or silica-based NPs conjugated with targeting moieties to enable imaging of specific cancer cells. We also cite and briefly discuss a few non-targeted systems for completeness. We summarize common synthetic approaches to these materials, and then survey the most recent imaging applications of silica-based nanoparticles in cancer. The field of theranostics is particularly important and stimulating, so, even though it is not the central topic of this paper, we have included some significant examples. We conclude with a short section on NP-based systems already in clinical trials and examples of specific applications in childhood tumors. This review aims to describe and discuss, through focused examples, the great potential of these materials in the medical field, with the aim to encourage further research to implement applications, which today are still rare.

29 December 2016 in Nanotechnology
Verified
Journal Article
Closed access
PDF file
Stefania BiffiStefania Biffi
Stefania Biffi
LALaura Andolfi
Laura Andolfi
CCClaudia Caltagirone
Claudia Caltagirone
CGChiara Garrovo
Chiara Garrovo
AFAngela M Falchi
Angela M Falchi
SMSergio Murgia
Sergio Murgia
Herein we provided the first proof of principle for in vivo fluorescence optical imaging application using monoolein-based cubosomes in a healthy mouse animal model. This formulation, administered at a non-cytotoxic concentration, was capable of providing both exogenous contrast for NIR fluorescence imaging with very high efficiency and chemospecific information upon lifetime analysis. Time-resolved measurements of fluorescence after the intravenous injection of cubosomes revealed that the dye rapidly accumulated mainly in the liver, while lifetimes profiles obtained in vivo allowed for discriminating between free dye or dye embedded within the cubosome nanostructure after injection.

26 June 2013 in Nanoscale
Verified
Journal Article
Closed access
PDF file
EREnrico Rampazzo
Enrico Rampazzo
RVRebecca Voltan
Rebecca Voltan
LPLuca Petrizza
Luca Petrizza
NZNelsi Zaccheroni
Nelsi Zaccheroni
LPLuca Prodi
Luca Prodi
Paola SecchieroPaola Secchiero
Paola Secchiero
Silica-based luminescent nanoparticles (SiNPs) show promising prospects in nanomedicine in light of their chemical properties and versatility. In this study, we have characterized silica core–PEG shell SiNPs derivatized with PEG moieties (NP-PEG), with external amino- (NP-PEG-amino) or carboxy-groups (NP-PEG-carbo), both in cell cultures as well as in animal models. By using different techniques, we could demonstrate that these SiNPs were safe and did not exhibit appreciable cytotoxicity in different relevant cell models, of normal or cancer cell types, growing either in suspension (JVM-2 leukemic cell line and primary normal peripheral blood mononuclear cells) or in adherence (human hepatocarcinoma Huh7 and umbilical vein endothelial cells). Moreover, by multiparametric flow cytometry, we could demonstrate that the highest efficiency of cell uptake and entry was observed with NP-PEG-amino, with a stable persistence of the fluorescence signal associated with SiNPs in the loaded cell populations both in vitro and in vivo settings suggesting this as an innovative method for cell traceability and detection in whole organisms. Finally, experiments performed with the endocytosis inhibitor Genistein clearly suggested the involvement of a caveolae-mediated pathway in SiNP endocytosis. Overall, these data support the safe use of these SiNPs for diagnostic and therapeutic applications.

6 November 2015 in Oncotarget
Verified
Journal Article
Open access
LMLaura Mediani
Laura Mediani
FGFederica Gibellini
Federica Gibellini
JBJESSIKA BERTACCHINI
JESSIKA BERTACCHINI
CFChiara Frasson
Chiara Frasson
RBRaffaella Bosco
Raffaella Bosco
Sandra MarmiroliSandra Marmiroli
Sandra Marmiroli
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/mTOR signaling

1 September 2016 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
LPLuca Prodi
Luca Prodi
Stefania BiffiStefania Biffi
Stefania Biffi
LPLuca Petrizza
Luca Petrizza
CGChiara Garrovo
Chiara Garrovo
EREnrico Rampazzo
Enrico Rampazzo
PSPaola Secchiero
Paola Secchiero
Purpose: The aim of the present study was to develop nanoprobes with theranostic features, including – at the same time – photoacoustic, near-infrared (NIR) optical imaging, and photothermal properties, in a versatile and stable core–shell silica-polyethylene glycol (PEG) nanoparticle architecture. Materials and methods: We synthesized core–shell silica-PEG nanoparticles by a one-pot direct micelles approach. Fluorescence emission and photoacoustic and photothermal properties were obtained at the same time by appropriate doping with triethoxysilane-derivatized cyanine 5.5 (Cy5.5) and cyanine 7 (Cy7) dyes. The performances of these nanoprobes were measured in vitro, using nanoparticle suspensions in phosphate-buffered saline and blood, dedicated phantoms, and after incubation with MDA-MB-231 cells. Results: We obtained core–shell silica-PEG nanoparticles endowed with very high colloidal stability in water and in biological environment, with absorption and fluorescence emission in the NIR field. The presence of Cy5.5 and Cy7 dyes made it possible to reach a more reproducible and higher doping regime, producing fluorescence emission at a single excitation wavelength in two different channels, owing to the energy transfer processes within the nanoparticle. The nanoarchitecture and the presence of both Cy5.5 and Cy7 dyes provided a favorable agreement between fluorescence emission and quenching, to achieve optical imaging and photoacoustic and photothermal properties. Conclusion: We obtained rationally designed nanoparticles with outstanding stability in biological environment. At appropriate doping regimes, the presence of Cy5.5 and Cy7 dyes allowed us to tune fluorescence emission in the NIR for optical imaging and to exploit quenching processes for photoacoustic and photothermal capabilities. These nanostructures are promising in vivo theranostic tools for the near future.